Kiniksa Pharmaceuticals, Ltd. (KNSA)
NASDAQ: KNSA · IEX Real-Time Price · USD
26.12
+0.21 (0.81%)
Jul 26, 2024, 4:00 PM EDT - Market closed
Kiniksa Pharmaceuticals Analyst Ratings
Total Analysts
5
Consensus Rating
Strong Buy
Price Target
$32.00
Upside
+22.51%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Buy Maintains $30 → $34 | Buy | Maintains | $30 → $34 | +30.17% | Jul 23, 2024 |
| Wells Fargo | Wells Fargo | Buy Initiates $34 | Buy | Initiates | $34 | +30.17% | May 3, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $26 → $30 | Buy | Maintains | $26 → $30 | +14.85% | May 1, 2024 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $25 → $30 | Buy | Maintains | $25 → $30 | +14.85% | Apr 24, 2024 |
| Wedbush | Wedbush | Buy Maintains $23 → $25 | Buy | Maintains | $23 → $25 | -4.29% | Jan 2, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $22 → $32 | Strong Buy | Maintains | $22 → $32 | +22.51% | Jul 26, 2023 |
| JP Morgan | JP Morgan | Buy Maintains $19 → $20 | Buy | Maintains | $19 → $20 | -23.43% | Mar 9, 2023 |
| B of A Securities | B of A Securities | Strong Buy Maintains $37 → $34 | Strong Buy | Maintains | $37 → $34 | +30.17% | Dec 29, 2021 |
| B of A Securities | B of A Securities | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | Apr 1, 2020 |
| JMP Securities | JMP Securities | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Sep 17, 2018 |